MedPath

Norethindrone Acetate

Norethindrone Acetate Tablets USP

Approved
Approval ID

f73f9807-4af6-4faa-ba9a-656a47a4c5e0

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 31, 2015

Manufacturers
FDA

Teva Pharmaceuticals USA, Inc.

DUNS: 001627975

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Norethindrone Acetate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0555-0211
Application NumberANDA075951
Product Classification
M
Marketing Category
C73584
G
Generic Name
Norethindrone Acetate
Product Specifications
Route of AdministrationORAL
Effective DateOctober 31, 2015
FDA Product Classification

INGREDIENTS (4)

NORETHINDRONE ACETATEActive
Quantity: 5 mg in 1 1
Code: 9S44LIC7OJ
Classification: ACTIB
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Norethindrone Acetate - FDA Drug Approval Details